Beacon Bio
PrivateCambridge-based biotech building AI-designed inhaled therapies for chronic respiratory diseases.
Company
Founded
2023
Headquarters
Cambridge, United States
Financials
Total Funding
$53M
Sectors
Funding History
2 rounds Series A Jul 8, 2026
$42M Seed Feb 15, 2024
$11M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.